About us
Driving advances in precision genomics to safely accelerate the identification and bioproduction of advanced cell and gene therapies.
Genomic Vision is entering an exciting phase of growth and innovation, driven by the increasing demand for sophisticated and targeted advanced therapies and a regulatory focus on safety of those therapies.
Driven by our strong leadership team and guided by our experienced Board, we believe Genomic Vision is well-positioned to capitalize on the rapidly growing demand for highly accurate, fast, and accessible solutions for genome characterization of advanced therapies.
Our mission
At Genomic Vision, we deliver high-quality genomic solutions to improve quality control and bioproduction standards of advanced gene therapies at scale. Together with our partners and customers, we unlock the full potential of advanced therapies to improve the lives of patients worldwide.
Undoubtedly we have no questions to ask which are unanswerable. We must trust the perfection of the creation so far, as to believe that whatever curiosity the order of things has awakened in our minds, the order of things can satisfy. Every man’s condition is a solution in hieroglyphic to those inquiries he would put.
Our team
Supervisory Board
Florence Allouche
President
Eric Edery
Vice-President
Mohammad Afshar
Member
Executive Board
Aaron Bensimon
PhD., Co-founder, CEO
Lionel Seltz
CFO
Emilie Chataignier
Member
